| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10006586 | HBV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS30005801 | HIV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS30087419 | HIV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS30029652 | HIV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS20032106 | HPV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS20049880 | HPV | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
| TVIS44009179 | HTLV-1 | ENSG00000166840.14 | protein_coding | GLYATL1 | No | No | 92292 | Q969I3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLYATL1 |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0002307 |
| UniProt ID | Q969I3 |
| Regulation Type | substrate |
| PubMed IDs | 22475485 |
| Citations | Matsuo M, Terai K, Kameda N, Matsumoto A, Kurokawa Y, Funase Y, Nishikawa K, Sugaya N, Hiruta N, Kishimoto T: Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2012 Apr 20;420(4):901-6. doi: 10.1016/j.bbrc.2012.03.099. Epub 2012 Mar 27. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |
